Testing for Mycoplasma pneumoniae is generally undertaken for specimens of respiratory secretions from patients with clinical diagnosis of community-acquired pneumonia.
Month | Age (Years) | No. tested | No. positive | % positive | Macrolide resistance (A2063G in 23S rRNA gene) | ||
---|---|---|---|---|---|---|---|
No. tested | No. detected | % | |||||
January | <18 | 120 | 23 | 19.2 | 21 | 7 | 33.3 |
≥18 | 445 | 12 | 2.7 | 11 | 3 | 27.3 | |
February | <18 | 93 | 19 | 20.4 | 19 | 6 | 31.6 |
≥18 | 461 | 15 | 3.3 | 15 | 2 | 13.3 | |
March | <18 | 147 | 19 | 12.9 | 19 | 6 | 31.6 |
≥18 | 457 | 6 | 1.3 | 6 | 1 | 16.7 | |
April | <18 | 176 | 32 | 18.2 | 32 | 8 | 25.0 |
≥18 | 424 | 6 | 1.4 | 6 | 1 | 16.7 | |
May | <18 | 200 | 33 | 16.5 | 33 | 14 | 42.4 |
≥18 | 450 | 12 | 2.7 | 12 | 3 | 25.0 | |
June | <18 | 207 | 37 | 17.9 | 35 | 11 | 31.4 |
≥18 | 467 | 9 | 1.9 | 9 | 1* | 11.1 | |
July | <18 | 168 | 28 | 16.7 | 27 | 5 | 18.5 |
≥18 | 500 | 9 | 1.8 | 9 | 0 | 0.0 | |
August | <18 | 85 | 20 | 23.5 | 20 | 5 | 25.0 |
≥18 | 431 | 15 | 3.5 | 15 | 1 | 6.7 | |
September | <18 | 117 | 20 | 17.1 | 19 | 3 | 15.8 |
≥18 | 301 | 7 | 2.3 | 7 | 0 | 0.0 | |
October | <18 | 92 | 21 | 22.8 | 21 | 5 | 23.8 |
≥18 | 332 | 6 | 1.8 | 6 | 0 | 0.0 | |
November | <18 | 93 | 12 | 12.9 | 12 | 2 | 16.7 |
≥18 | 346 | 6 | 1.7 | 6 | 0 | 0.0 | |
December | <18 | 113 | 13 | 11.5 | 13 | 2 | 15.4 |
≥18 | 378 | 8 | 2.1 | 8 | 4 | 50.0 |
*A2064G for one specimen
Remarks: